Literature DB >> 26466767

PROS1 genotype phenotype relationships in a large cohort of adults with suspicion of inherited quantitative protein S deficiency.

Martine Alhenc-Gelas1, Genevieve Plu-Bureau, Marie Hélène Horellou, Antoine Rauch, Pierre Suchon.   

Abstract

Inherited protein S deficiency (PSD) is an established risk factor for venous thromboembolism (VTE). However, data are conflicting concerning risk of VTE associated with decreased free PS level (FPS) and information on PROS1 genotype-phenotype relationship is sparse. In a retrospective cohort of 579 patients with inherited type I/III deficiency suspicion, PROS1 genotyping was performed and the effect of genotype on FPS and on VTE risk was investigated. We found 116 (including 65 novel) detrimental mutations (DM) in 222 (type I/III in 194, type II in 28), PS Heerlen in 74, possibly non DM in 38 and no mutation in 245 subjects. Among DMs, type I/IIIDMs only were found in subjects with FPS< 30 %. Prevalence of type I/III DM decreased with increasing FPS level. Risk of VT associated with FPS level and genotype was studied in the 467 subjects with personal or family history of thrombosis. Only type I/IIIDM carriers presented with an increased risk of VTE [1.41 (95 %CI (1.05-1.89)] compared to subjects with no mutation. Among the group of type I/IIIDM heterozygotes and subjects with no mutation, the optimal FPS cut-off point for identifying subjects at increased VTE risk was searched for. We found that only subjects with FPS< 30 % and type I/IIIDM presented with an increased risk [1.48 (95 %CI 1.08-2.04)]. Our findings confirm the value of a cut-off FPS level for identifying subjects at increased VTE risk far below the lower limit of the normal range and suggest a place for PROS1 genotyping in PSD diagnosis strategy.

Entities:  

Keywords:  Coagulation inhibitor; PROS1; protein S; thrombophilia; venous thrombosis

Mesh:

Substances:

Year:  2015        PMID: 26466767     DOI: 10.1160/TH15-05-0391

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN: 0340-6245            Impact factor:   5.249


  5 in total

1.  Distinctive regional-specific PROS1 mutation spectrum in Southern China.

Authors:  Nelson C N Chan; Chi-Keung Cheng; Kelvin C F Chan; Connie M L Wong; Kin-Mang Lau; Joyce H Y Kwong; Natalie P H Chan; Wai-Shan Wong; Eudora Y D Chow; Michael L G Wong; Raymond W Chu; Rosalina K L Ip; Margaret H L Ng
Journal:  J Thromb Thrombolysis       Date:  2018-07       Impact factor: 2.300

2.  Whole-exome sequencing in evaluation of patients with venous thromboembolism.

Authors:  Eun-Ju Lee; Daniel J Dykas; Andrew D Leavitt; Rodney M Camire; Eduard Ebberink; Pablo García de Frutos; Kavitha Gnanasambandan; Sean X Gu; James A Huntington; Steven R Lentz; Koen Mertens; Christopher R Parish; Alireza R Rezaie; Peter P Sayeski; Caroline Cromwell; Noffar Bar; Stephanie Halene; Natalia Neparidze; Terri L Parker; Adrienne J Burns; Anne Dumont; Xiaopan Yao; Cassius Iyad Ochoa Chaar; Jean M Connors; Allen E Bale; Alfred Ian Lee
Journal:  Blood Adv       Date:  2017-06-29

3.  PROS1 novel splice-site variant decreases protein S expression in patients from two families with thrombotic disease.

Authors:  Juliane Menezes; Célia Ventura; João Matos Costa; Elsa Parreira; Luísa Romão; João Gonçalves
Journal:  Clin Case Rep       Date:  2017-11-03

Review 4.  Inherited Thrombophilia in the Era of Direct Oral Anticoagulants.

Authors:  Lina Khider; Nicolas Gendron; Laetitia Mauge
Journal:  Int J Mol Sci       Date:  2022-02-05       Impact factor: 5.923

Review 5.  Inflammatory Bowel Disease: An Indication to Screen for Thrombophilia?

Authors:  Nour M Moukalled; Jana G Hashash; Ali T Taher
Journal:  Diseases       Date:  2022-02-23
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.